QI
TTOO

QS Investors’s T2 Biosystems, Inc TTOO Stock Holding History

QS Investors’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$133K Hold
22
– – ﹤0.01% 1081
2021
Q1 		$181K Sell
22
-1
-4% -$10.6K ﹤0.01% 1131
2020
Q4 		$143K Hold
23
– – ﹤0.01% 1124
2020
Q3 		$158K Buy
+23
New +$170K ﹤0.01% 1097

Other funds holding TTOO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KFS
Kelly Financial Services Braintree, Massachusetts $467M AUM 21.13% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

QS Investors's TTOO Position: Q2 2021 in Review

QS Investors held its T2 Biosystems, Inc (TTOO) position steady in Q2 2021 at 22 shares worth $133K. The position accounts for ﹤0.01% of the portfolio, ranked #1081.

QS Investors first reported a position in TTOO in Q3 2020 and has held it in 4 quarters since. The position peaked at $181K in Q1 2021. 78 funds tracked by Wall St. Rank hold TTOO as of Q2 2021.

  • QS Investors held 22 shares of T2 Biosystems, Inc worth $133K as of Q2 2021.
  • QS Investors left its T2 Biosystems, Inc share count unchanged in Q2 2021.
  • T2 Biosystems, Inc made up ﹤0.01% of QS Investors's portfolio in Q2 2021, its #1081 holding.
  • QS Investors first reported a position in T2 Biosystems, Inc in Q3 2020 and has held it in 4 quarters since.
  • QS Investors's T2 Biosystems, Inc position peaked at $181K in Q1 2021.
  • 78 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q2 2021.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.